Pinion John Richard — SEC Form 4 filings

SEC reporting owner CIK 1648096. 4 Form 4 filings on record with FilingPulse; latest filed 2026-04-20.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-03-05 to 2026-04-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ultragenyx Pharmaceutical Inc. (RARE)See Remarks43 legs · 28,641 sh · $1,060,88411

Form 4 filings — Pinion John Richard

FiledFormIssuerReported transactionsSource
2026-04-204Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 23,116 @ $0 · Grant/award (A): 79,936 (derivative) @ $0EDGAR
2026-03-034Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 11,137 @ $0 · Sale (S): 10,029 @ $22.80EDGAR
2025-03-044Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 14,494 @ $0 · Grant/award (A): 18,443 @ $0 · Sale (S): 14,439 @ $42.10 · Tax withholding (F): 31 @ $42.92 · Grant/award (A): 26,074 (derivative) @ $0EDGAR
2024-03-054Ultragenyx Pharmaceutical Inc. (RARE)Grant/award (A): 17,800 @ $0 · Grant/award (A): 957 @ $0 · Tax withholding (F): 60 @ $53.69 · Sale (S): 4,173 @ $53.76 · Grant/award (A): 31,400 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1648096 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →